Company · CIK 0000899923 · SIC 2835 — In Vitro & In Vivo Diagnostic Substances · Nasdaq
MYRIAD GENETICS INC · MYGN
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 21, 2026 FForm 4 → | Sep 22, 4:12 pm EDT | Benjamin Richard WheelerChief Financial Officer | 2,555 | $4.01 | $10,246 | 287,193 | — | |
| Sep 16, 2026 AForm 4 → | Sep 17, 4:34 pm EDT | Vishal SikriEVP, Commercial | 257,731 | — | — | 351,224 | — | |
| Sep 3, 2026 FForm 4 → | Sep 8, 4:18 pm EDT | Jennifer Lynne FoxChief Legal Officer | 4,398 | $3.23 | $14,206 | 305,964 | — | |
| Aug 16, 2026 FForm 4 → | Aug 17, 4:26 pm EDT | Benjamin Richard WheelerChief Financial Officer | 8,761 | $3.03 | $26,546 | 289,748 | — | |
| Jun 11, 2026 AForm 4 → | Jun 12, 6:06 pm EDT | Samraat S. RahaPresident and CEO, Director | 3,542 | $3.94 | $13,941 | 1,068,083 | — | |
| Jun 11, 2026 AForm 4 → | Jun 12, 6:05 pm EDT | Brian J DonnellyChief Commerical Officer | 5,000 | $3.94 | $19,680 | 573,363 | — | |
| Jun 8, 2026 SForm 4 → | Jun 9, 4:20 pm EDT | Rashmi KumarDirector | 15,000 | $4.46 | $66,843 | 171,889 | −8.03% | 10b5-1 |
| Jun 4, 2026 AForm 4 → | Jun 5, 4:25 pm EDT | Daniel SkovronskyDirector | 59,701 | — | — | 195,507 | — | |
| Jun 4, 2026 AForm 4 → | Jun 5, 4:25 pm EDT | Lee Nisley NewcomerDirector | 59,701 | — | — | 191,842 | — | |
| Jun 4, 2026 AForm 4 → | Jun 5, 4:25 pm EDT | Mark Steven DavisDirector | 59,701 | — | — | 106,665 | — | |
| Jun 4, 2026 AForm 4 → | Jun 5, 4:25 pm EDT | S. Louise PhanstielDirector | 59,701 | — | — | 341,652 | — | |
| Jun 4, 2026 AForm 4 → | Jun 5, 4:25 pm EDT | Heinrich DreismannDirector | 59,701 | — | — | 231,145 | — | |
| Jun 4, 2026 AForm 4 → | Jun 5, 4:25 pm EDT | Colleen F ReitanDirector | 59,701 | — | — | 152,030 | — | |
| Jun 4, 2026 AForm 4 → | Jun 5, 4:24 pm EDT | Paul BisaroDirector | 59,701 | — | — | 157,142 | — | |
| Jun 4, 2026 AForm 4 → | Jun 5, 4:24 pm EDT | Rashmi KumarDirector | 59,701 | — | — | 186,889 | — | |
| Mar 12, 2019 SForm 4 → | Mar 12, 5:56 pm EDT | Ralph L McDadePresident Myriad RBM, Inc. | 1,975 | $31.00 | $61,225 | 122,604 | −1.59% | plan? |
| Jan 2, 2019 DForm 4 → | Jan 3, 1:20 pm EST | Bernard TobinPresident Crescendo BioScience | 3,734 | $29.00 | $108,286 | 157,752 | — | plan? |
| Nov 29, 2018 AForm 4 → | Nov 30, 12:57 pm EST | S. Louise PhanstielDirector | 9,360 | — | — | 40,103 | — | plan? |
| Nov 29, 2018 AForm 4 → | Nov 30, 12:54 pm EST | Dennis LangerDirector | 9,360 | — | — | 49,103 | — | plan? |
| Nov 29, 2018 AForm 4 → | Nov 30, 12:52 pm EST | Walter Gilbert Ph.D.Director | 9,360 | — | — | 36,603 | — | plan? |
| Nov 29, 2018 AForm 4 → | Nov 30, 12:49 pm EST | Heinrich DreismannDirector | 9,360 | — | — | 43,103 | — | plan? |
| Nov 29, 2018 AForm 4 → | Nov 30, 12:46 pm EST | Lawrence C BestDirector | 9,360 | — | — | 49,103 | — | plan? |
| Nov 29, 2018 AForm 4 → | Nov 30, 12:41 pm EST | John T HendersonDirector | 9,360 | — | — | 59,103 | — | plan? |
| Oct 17, 2018 DForm 4 → | Oct 19, 11:46 am EDT | Richard Bryan RiggsbeeChief Financial Officer | 3,327 | $44.45 | $147,885 | 146,966 | — | plan? |
| Sep 30, 2018 DForm 4 → | Oct 2, 9:18 am EDT | Ralph L McDadePresident Myriad RBM, Inc. | 5,313 | $46.00 | $244,398 | 124,265 | — | plan? |
| Sep 30, 2018 DForm 4 → | Oct 2, 9:16 am EDT | Mark VerrattiPresident Assurex Health Inc. | 725 | $46.00 | $33,350 | 85,578 | — | plan? |
| Sep 30, 2018 DForm 4 → | Oct 2, 9:13 am EDT | Gary A. KingExec. VP International Ops | 7,153 | $46.00 | $329,038 | 133,973 | — | plan? |
| Sep 30, 2018 DForm 4 → | Oct 2, 9:10 am EDT | Walter Lloyd SandersPresident Myriad Oncology | 1,258 | $46.00 | $57,868 | 36,195 | — | plan? |
| Sep 30, 2018 DForm 4 → | Oct 2, 9:05 am EDT | Bernard TobinPresident Crescendo BioScience | 11,107 | $46.00 | $510,922 | 161,486 | — | plan? |
| Sep 30, 2018 DForm 4 → | Oct 2, 9:02 am EDT | Alexander FordPresident, MGL | 8,483 | $46.00 | $390,218 | 120,524 | — | plan? |
| Sep 30, 2018 DForm 4 → | Oct 2, 8:58 am EDT | Jerry S LanchburyChief Scientific Officer | 10,701 | $46.00 | $492,246 | 166,049 | — | plan? |
| Sep 30, 2018 DForm 4 → | Oct 2, 8:53 am EDT | Richard M MarshE.V.P., General Counsel | 10,542 | $46.00 | $484,932 | 144,174 | — | plan? |
| Sep 30, 2018 DForm 4 → | Oct 2, 8:49 am EDT | Richard Bryan RiggsbeeChief Financial Officer | 11,942 | $46.00 | $549,332 | 150,293 | — | plan? |
| Sep 30, 2018 DForm 4 → | Oct 2, 8:45 am EDT | Mark Christopher CaponePresident & C.E.O. | 27,022 | $46.00 | $1,243,012 | 440,833 | — | plan? |
| Sep 25, 2018 DForm 4 → | Sep 26, 2:55 pm EDT | Mark Christopher CaponePresident & C.E.O. | 18,295 | $46.65 | $853,462 | 467,855 | — | plan? |
| Sep 25, 2018 DForm 4 → | Sep 26, 2:50 pm EDT | Alexander FordPresident, MGL | 6,653 | $46.65 | $310,362 | 129,007 | — | plan? |
| Sep 25, 2018 DForm 4 → | Sep 26, 2:43 pm EDT | Jerry S LanchburyChief Scientific Officer | 5,544 | $46.65 | $258,628 | 176,750 | — | plan? |
| Sep 25, 2018 DForm 4 → | Sep 26, 2:40 pm EDT | Richard M MarshE.V.P., General Counsel | 5,544 | $46.65 | $258,628 | 154,716 | — | plan? |
| Sep 25, 2018 DForm 4 → | Sep 26, 2:36 pm EDT | Richard Bryan RiggsbeeChief Financial Officer | 6,653 | $46.65 | $310,362 | 162,235 | — | plan? |
| Sep 25, 2018 DForm 4 → | Sep 26, 2:33 pm EDT | Mark VerrattiPresident Assurex Health Inc. | 2,897 | $46.65 | $135,145 | 86,303 | — | plan? |
| Sep 25, 2018 DForm 4 → | Sep 26, 2:30 pm EDT | Gary A. KingExec. VP International Ops | 3,327 | $46.65 | $155,205 | 141,126 | — | plan? |
| Sep 25, 2018 DForm 4 → | Sep 26, 2:27 pm EDT | Bernard TobinPresident Crescendo BioScience | 4,958 | $46.65 | $231,291 | 172,593 | — | plan? |
| Sep 25, 2018 DForm 4 → | Sep 26, 2:23 pm EDT | Walter Lloyd SandersPresident Myriad Oncology | 1,664 | $46.65 | $77,626 | 37,453 | — | plan? |
| Sep 25, 2018 DForm 4 → | Sep 26, 2:20 pm EDT | Ralph L McDadePresident Myriad RBM, Inc. | 2,952 | $46.65 | $137,711 | 129,578 | — | plan? |
| Sep 19, 2018 AForm 4 → | Sep 21, 12:27 pm EDT | Ralph L McDadePresident Myriad RBM, Inc. | 27,000 | — | — | 132,530 | — | plan? |
| Sep 19, 2018 AForm 4 → | Sep 21, 12:25 pm EDT | Bernard TobinPresident Crescendo BioScience | 35,000 | — | — | 177,551 | — | plan? |
| Sep 19, 2018 AForm 4 → | Sep 21, 12:22 pm EDT | Gary A. KingExec. VP International Ops | 27,000 | — | — | 144,453 | — | plan? |
| Sep 19, 2018 AForm 4 → | Sep 21, 12:19 pm EDT | Mark VerrattiPresident Assurex Health Inc. | 40,000 | — | — | 89,200 | — | plan? |
| Sep 19, 2018 AForm 4 → | Sep 21, 12:14 pm EDT | Alexander FordPresident, MGL | 60,000 | — | — | 135,660 | — | plan? |
| Sep 19, 2018 AForm 4 → | Sep 21, 12:11 pm EDT | Jerry S LanchburyChief Scientific Officer | 50,000 | — | — | 182,294 | — | plan? |
| Sep 19, 2018 AForm 4 → | Sep 21, 12:08 pm EDT | Richard M MarshE.V.P., General Counsel | 50,000 | — | — | 160,260 | — | plan? |
| Sep 19, 2018 AForm 4 → | Sep 21, 12:06 pm EDT | Richard Bryan RiggsbeeChief Financial Officer | 60,000 | — | — | 168,888 | — | plan? |
| Sep 19, 2018 AForm 4 → | Sep 21, 12:02 pm EDT | Mark Christopher CaponePresident & C.E.O. | 165,000 | — | — | 486,150 | — | plan? |
| Sep 17, 2018 DForm 4 → | Sep 18, 4:22 pm EDT | Jerry S LanchburyChief Scientific Officer | 6,515 | $46.35 | $301,970 | 132,294 | — | plan? |
| Sep 17, 2018 DForm 4 → | Sep 18, 4:15 pm EDT | Mark Christopher CaponePresident & C.E.O. | 11,025 | $46.35 | $511,009 | 321,150 | — | plan? |
| Sep 17, 2018 DForm 4 → | Sep 18, 4:13 pm EDT | Richard M MarshE.V.P., General Counsel | 6,314 | $46.35 | $292,654 | 110,260 | — | plan? |
| Sep 17, 2018 DForm 4 → | Sep 18, 2:35 pm EDT | Gary A. KingExec. VP International Ops | 5,101 | $46.35 | $236,431 | 117,453 | — | plan? |
| Sep 17, 2018 DForm 4 → | Sep 18, 2:26 pm EDT | Walter Lloyd SandersPresident Myriad Oncology | 844 | $46.35 | $39,119 | 24,117 | — | plan? |
| Sep 17, 2018 DForm 4 → | Sep 18, 2:21 pm EDT | Alexander FordPresident, MGL | 1,830 | $46.35 | $84,821 | 75,660 | — | plan? |
| Sep 17, 2018 DForm 4 → | Sep 18, 2:18 pm EDT | Ralph L McDadePresident Myriad RBM, Inc. | 3,148 | $46.35 | $145,910 | 105,530 | — | plan? |
| Jul 11, 2018 SForm 4 → | Jul 13, 4:25 pm EDT | Jerry S LanchburyChief Scientific Officer | 50,000 | $43.34 | $2,167,040 | 138,809 | −26.5% | plan? |
| Jul 11, 2018 MForm 4 → | Jul 13, 4:25 pm EDT | Jerry S LanchburyChief Scientific Officer | 50,000 | $30.34 | $1,517,000 | 142,670 | — | plan? |
| Jul 11, 2018 SForm 4 → | Jul 13, 4:23 pm EDT | John T HendersonDirector | 30,000 | $42.06 | $1,261,785 | 49,743 | −37.6% | plan? |
| Jul 11, 2018 MForm 4 → | Jul 13, 4:23 pm EDT | John T HendersonDirector | 30,000 | $24.39 | $731,700 | 59,743 | — | plan? |
| Jul 11, 2018 SForm 4 → | Jul 13, 4:19 pm EDT | Richard M MarshE.V.P., General Counsel | 70,672 | $42.88 | $3,030,220 | 124,197 | −36.3% | plan? |
| Jul 11, 2018 GMForm 4 → | Jul 13, 4:19 pm EDT | Richard M MarshE.V.P., General Counsel | 78,295 | $23.11 | $1,633,230 | 116,574 | — | plan? |
| Jul 11, 2018 SForm 4 → | Jul 13, 4:16 pm EDT | Mark Christopher CaponePresident & C.E.O. | 80,000 | $41.00 | $3,280,000 | 332,175 | −19.4% | plan? |
| Jul 11, 2018 MForm 4 → | Jul 13, 4:16 pm EDT | Mark Christopher CaponePresident & C.E.O. | 80,000 | $30.12 | $2,409,600 | 334,521 | — | plan? |
| Jun 22, 2018 GForm 5 → | Jul 13, 4:21 pm EDT | Richard Bryan RiggsbeeChief Financial Officer | 1,100 | — | — | 108,888 | — | plan? |
| Jun 18, 2018 SForm 4 → | Jun 19, 4:49 pm EDT | Jerry S LanchburyChief Scientific Officer | 60,000 | $40.12 | $2,407,200 | 138,809 | −30.2% | plan? |
| Jun 18, 2018 MForm 4 → | Jun 19, 4:49 pm EDT | Jerry S LanchburyChief Scientific Officer | 60,000 | $30.12 | $1,807,200 | 141,155 | — | plan? |
| Jun 18, 2018 SForm 4 → | Jun 19, 4:46 pm EDT | Richard M MarshE.V.P., General Counsel | 33,000 | $40.00 | $1,320,000 | 124,197 | −21.0% | plan? |
| Jun 18, 2018 MForm 4 → | Jun 19, 4:46 pm EDT | Richard M MarshE.V.P., General Counsel | 33,000 | $30.34 | $1,001,220 | 157,197 | — | plan? |
| Jun 6, 2018 SForm 4 → | Jun 8, 5:37 pm EDT | Dennis LangerDirector | 20,369 | $39.35 | $801,594 | 39,743 | −33.9% | plan? |
| Jun 6, 2018 MForm 4 → | Jun 8, 5:37 pm EDT | Dennis LangerDirector | 20,369 | $21.29 | $433,656 | 53,407 | — | plan? |
| Jun 5, 2018 SForm 4 → | Jun 7, 4:00 pm EDT | Walter Gilbert Ph.D.Director | 30,000 | $39.69 | $1,190,589 | 27,243 | −52.4% | plan? |
| Jun 5, 2018 MForm 4 → | Jun 7, 4:00 pm EDT | Walter Gilbert Ph.D.Director | 30,000 | $24.39 | $731,700 | 28,432 | — | plan? |
| Jun 1, 2018 SForm 4 → | Jun 5, 5:45 pm EDT | Dennis LangerDirector | 49,631 | $39.30 | $1,950,277 | 39,743 | −55.5% | plan? |
| Jun 1, 2018 MForm 4 → | Jun 5, 5:45 pm EDT | Dennis LangerDirector | 49,631 | $23.79 | $1,180,944 | 40,970 | — | plan? |
| May 30, 2018 SForm 4 → | Jun 1, 5:43 pm EDT | Mark Christopher CaponePresident & C.E.O. | 90,000 | $38.00 | $3,420,000 | 332,175 | −21.3% | plan? |
| May 30, 2018 MForm 4 → | Jun 1, 5:43 pm EDT | Mark Christopher CaponePresident & C.E.O. | 90,000 | $22.93 | $2,063,700 | 422,175 | — | plan? |
| May 30, 2018 SForm 4 → | Jun 1, 4:43 pm EDT | Richard M MarshE.V.P., General Counsel | 33,139 | $38.00 | $1,259,282 | 123,769 | −21.1% | plan? |
| May 30, 2018 MForm 4 → | Jun 1, 4:43 pm EDT | Richard M MarshE.V.P., General Counsel | 33,139 | $30.34 | $1,005,437 | 156,908 | — | plan? |
| May 30, 2018 SForm 4 → | Jun 1, 4:37 pm EDT | Dennis LangerDirector | 10,000 | $37.92 | $379,245 | 39,743 | −20.1% | plan? |
| May 30, 2018 MForm 4 → | Jun 1, 4:37 pm EDT | Dennis LangerDirector | 10,000 | $24.39 | $243,900 | 49,743 | — | plan? |
| May 21, 2018 SForm 4 → | May 21, 7:54 pm EDT | Dennis LangerDirector | 10,000 | $35.90 | $359,000 | 39,743 | −20.1% | plan? |
| May 21, 2018 MForm 4 → | May 21, 7:54 pm EDT | Dennis LangerDirector | 10,000 | $24.39 | $243,900 | 49,743 | — | plan? |
| Jan 22, 2018 SForm 4 → | Jan 22, 6:16 pm EST | Gary A. KingExec. VP International Ops | 34,445 | $39.67 | $1,366,588 | 121,968 | −22.0% | plan? |
| Jan 22, 2018 MForm 4 → | Jan 22, 6:16 pm EST | Gary A. KingExec. VP International Ops | 34,445 | $19.28 | $664,110 | 126,413 | — | plan? |
| Jan 22, 2018 SForm 4 → | Jan 22, 6:12 pm EST | Richard M MarshE.V.P., General Counsel | 37,654 | $40.25 | $1,515,611 | 119,994 | −23.9% | plan? |
| Jan 22, 2018 MForm 4 → | Jan 22, 6:12 pm EST | Richard M MarshE.V.P., General Counsel | 41,429 | $29.79 | $1,234,138 | 123,769 | — | plan? |
| Jan 18, 2018 SForm 4 → | Jan 19, 2:26 pm EST | Richard M MarshE.V.P., General Counsel | 40,000 | $38.25 | $1,530,000 | 119,994 | −25.0% | plan? |
| Jan 18, 2018 MForm 4 → | Jan 19, 2:26 pm EST | Richard M MarshE.V.P., General Counsel | 40,000 | $30.12 | $1,204,800 | 159,994 | — | plan? |
| Jan 18, 2018 SForm 4 → | Jan 19, 2:21 pm EST | Gary A. KingExec. VP International Ops | 3,120 | $38.12 | $118,934 | 121,968 | −2.49% | plan? |
| Jan 18, 2018 MForm 4 → | Jan 19, 2:21 pm EST | Gary A. KingExec. VP International Ops | 3,120 | $14.88 | $46,426 | 125,088 | — | plan? |
| Jan 12, 2018 SForm 4 → | Jan 16, 3:18 pm EST | Richard M MarshE.V.P., General Counsel | 13,759 | $36.25 | $498,764 | 119,994 | −10.3% | plan? |
| Jan 2, 2018 DForm 4 → | Jan 3, 7:39 pm EST | Bernard TobinPresident Crescendo BioScience | 3,621 | $34.91 | $126,409 | 142,551 | — | plan? |
| Dec 14, 2017 SForm 4 → | Dec 15, 3:09 pm EST | Walter Gilbert Ph.D.Director | 7,500 | $33.19 | $248,925 | 27,243 | −21.6% | plan? |
| Dec 11, 2017 SForm 4 → | Dec 12, 12:16 pm EST | Heinrich DreismannDirector | 6,000 | $33.50 | $201,000 | 33,743 | −15.1% | plan? |
| Nov 30, 2017 AForm 4 → | Nov 30, 7:28 pm EST | Lawrence C BestDirector | 7,219 | — | — | 39,743 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 11, 2018 MForm 4 → | Jul 13, 4:25 pm EDT | Jerry S LanchburyChief Scientific Officer | 50,000 | — | — | 0 | — | |
| Jul 11, 2018 MForm 4 → | Jul 13, 4:23 pm EDT | John T HendersonDirector | 30,000 | — | — | 0 | — | |
| Jul 11, 2018 MForm 4 → | Jul 13, 4:19 pm EDT | Richard M MarshE.V.P., General Counsel | 70,672 | — | — | 0 | — | |
| Jul 11, 2018 MForm 4 → | Jul 13, 4:16 pm EDT | Mark Christopher CaponePresident & C.E.O. | 80,000 | — | — | 0 | — | |
| Jun 18, 2018 MForm 4 → | Jun 19, 4:49 pm EDT | Jerry S LanchburyChief Scientific Officer | 60,000 | — | — | 0 | — | |
| Jun 18, 2018 MForm 4 → | Jun 19, 4:46 pm EDT | Richard M MarshE.V.P., General Counsel | 33,000 | — | — | 0 | — | |
| Jun 6, 2018 MForm 4 → | Jun 8, 5:37 pm EDT | Dennis LangerDirector | 20,369 | — | — | 0 | — | |
| Jun 5, 2018 MForm 4 → | Jun 7, 4:00 pm EDT | Walter Gilbert Ph.D.Director | 30,000 | — | — | 0 | — | |
| Jun 1, 2018 MForm 4 → | Jun 5, 5:45 pm EDT | Dennis LangerDirector | 49,631 | — | — | 0 | — | |
| May 30, 2018 MForm 4 → | Jun 1, 5:43 pm EDT | Mark Christopher CaponePresident & C.E.O. | 90,000 | — | — | 0 | — | |
| May 30, 2018 MForm 4 → | Jun 1, 4:43 pm EDT | Richard M MarshE.V.P., General Counsel | 33,139 | — | — | 33,000 | — | |
| May 30, 2018 MForm 4 → | Jun 1, 4:37 pm EDT | Dennis LangerDirector | 10,000 | — | — | 10,000 | — | |
| May 21, 2018 MForm 4 → | May 21, 7:54 pm EDT | Dennis LangerDirector | 10,000 | $35.90 | $359,000 | 20,000 | — | |
| Jan 22, 2018 MForm 4 → | Jan 22, 6:16 pm EST | Gary A. KingExec. VP International Ops | 34,445 | — | — | 27,432 | — | |
| Jan 22, 2018 MForm 4 → | Jan 22, 6:12 pm EST | Richard M MarshE.V.P., General Counsel | 41,429 | — | — | 0 | — | |
| Jan 18, 2018 MForm 4 → | Jan 19, 2:26 pm EST | Richard M MarshE.V.P., General Counsel | 40,000 | — | — | 37,654 | — | |
| Jan 18, 2018 MForm 4 → | Jan 19, 2:21 pm EST | Gary A. KingExec. VP International Ops | 3,120 | — | — | 0 | — | |
| Sep 1, 2017 MForm 4 → | Sep 5, 2:08 pm EDT | John T HendersonDirector | 30,000 | — | — | 0 | — | |
| Sep 9, 2016 MForm 4 → | Sep 13, 10:38 am EDT | John T HendersonDirector | 30,000 | — | — | 0 | — | |
| Jun 21, 2016 MForm 4 → | Jun 22, 5:05 pm EDT | Alexander FordPresident, MGL | 16,449 | — | — | 0 | — | |
| Jun 16, 2016 MForm 4 → | Jun 16, 5:10 pm EDT | Richard M MarshE.V.P., General Counsel | 4,170 | — | — | 0 | — | |
| Apr 6, 2016 MForm 4 → | Apr 8, 6:27 pm EDT | Gary A. KingExec. VP International Ops | 15,000 | — | — | 4,445 | — | |
| Apr 1, 2016 MForm 4 → | Apr 5, 10:24 am EDT | Gary A. KingExec. VP International Ops | 15,000 | — | — | 3,120 | — | |
| Nov 5, 2015 MForm 4 → | Nov 5, 6:14 pm EST | Heinrich DreismannDirector | 60,000 | — | — | 0 | — | |
| Nov 4, 2015 MForm 4 → | Nov 5, 4:26 pm EST | Richard M MarshE.V.P., General Counsel | 35,000 | — | — | 0 | — | |
| Oct 28, 2015 MForm 4 → | Oct 28, 6:34 pm EDT | Gary A. KingExec. VP International Ops | 10,000 | — | — | 11,830 | — | |
| Oct 28, 2015 MForm 4 → | Oct 28, 4:16 pm EDT | Jerry S LanchburyChief Scientific Officer | 50,962 | — | — | 0 | — | |
| Oct 23, 2015 MForm 4 → | Oct 27, 5:01 pm EDT | Jerry S LanchburyChief Scientific Officer | 24,767 | — | — | 50,962 | — | |
| Oct 6, 2015 MForm 4 → | Oct 7, 4:56 pm EDT | Richard M MarshE.V.P., General Counsel | 6,208 | — | — | 0 | — | |
| Sep 16, 2015 MForm 4 → | Sep 17, 6:32 pm EDT | Richard M MarshE.V.P., General Counsel | 35,000 | — | — | 35,000 | — | |
| Sep 15, 2015 MForm 4 → | Sep 17, 6:40 pm EDT | Jerry S LanchburyChief Scientific Officer | 60,270 | — | — | 0 | — | |
| Sep 14, 2015 MForm 4 → | Sep 16, 4:34 pm EDT | Gary A. KingExec. VP International Ops | 14,562 | — | — | 57,432 | — | |
| Sep 3, 2015 MForm 4 → | Sep 8, 4:08 pm EDT | Gary A. KingExec. VP International Ops | 25,438 | — | — | 71,994 | — | |
| Sep 2, 2015 MForm 4 → | Sep 2, 4:24 pm EDT | Gary A. KingExec. VP International Ops | 15,000 | — | — | 19,445 | — | |
| Aug 28, 2015 MForm 4 → | Aug 31, 4:14 pm EDT | Gary A. KingExec. VP International Ops | 30,000 | — | — | 18,120 | — | |
| May 6, 2015 MForm 4 → | May 8, 4:17 pm EDT | Peter D MeldrumPresident & C.E.O., Director | 5,555 | — | — | 0 | — | |
| Mar 2, 2015 MForm 4 → | Mar 3, 5:24 pm EST | Richard M MarshE.V.P., General Counsel | 5,555 | — | — | 0 | — |